Vesselon Email Format
Pharmaceutical ManufacturingConnecticut, United States2-10 Employees
Vesselon is a pharmaceutical manufacturing company based in Norwalk, Connecticut. It develops patentable therapeutics using an FDA-approved biophysically activatable lipid microsphere and a self-assembling liposome platform, with the aim of increasing how drugs interact with tissues and cells. The platform is designed to extend patent protection and support a pipeline of proprietary drug candidates, even as the company operates with a small team. In 2019, Vesselon entered into an exclusive license with Temple University to enable systemic delivery of oncolytic viruses for solid tumors. The company is advancing oncology programs, including VEST, a therapeutic immuno-oncology complex designed to protect and target tumors.